Timing and Causes of Readmission After Acute Heart Failure Hospitalization—Insights From the Heart Failure Network Trials
详细信息 查看全文
- 作者：Justin M. Vader ; MD ; MPHS1 ; jvader@dom.wustl.edu" class="auth_mail" title="E-mail the corresponding author ; Shane J. LaRue ; MD ; MPHS1 ; Susanna R. Stevens ; MS2 ; Robert J. Mentz ; MD2 ; Adam D. DeVore ; MD2 ; Anuradha Lala ; MD3 ; 4 ; John D. Groarke ; MB ; MPH4 ; Omar F. AbouEzzeddine ; MD5 ; Shannon M. Dunlay ; MD ; MS5 ; Justin L. Grodin ; MD6 ; Victor G. Dá ; vila-Romá ; n ; MD1 ; Lisa de las Fuentes ; MD ; MS1
- 关键词：Cardiorenal ; ACE inhibitor ; RAAS
- 刊名：Journal of Cardiac Failure
- 出版年：2016
- 出版时间：November 2016
- 年：2016
- 卷：22
- 期：11
- 页码：875-883
- 全文大小：321 K
文摘
- •
Early readmission after HF hospitalization was often due to cardiovascular comorbidity.
- •
ACEI/ARB use was associated with less risk of early readmission/death.
- •
Hypokalemia, but not hyperkalemia, was associated with increased cardiovascular readmission/death.
- •
Despite detailed physical examination data from a trial cohort, readmission prediction was limited.